363 related articles for article (PubMed ID: 20345732)
1. The efficacy and safety of testosterone undecanoate (Nebido(®)) in testosterone deficiency syndrome in Korean: a multicenter prospective study.
Moon DG; Park MG; Lee SW; Park K; Park JK; Kim SW; Park NC; Ahn TY; Paick JS; Seo JT; Yang DY; Lee JY; Kim JJ
J Sex Med; 2010 Jun; 7(6):2253-2260. PubMed ID: 20345732
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of combination treatment with injectable testosterone undecanoate and daily tadalafil for erectile dysfunction with testosterone deficiency syndrome.
Park MG; Yeo JK; Cho DY; Kim JW; Kim JW; Oh MM; Kim JJ; Moon du G
J Sex Med; 2015 Apr; 12(4):966-74. PubMed ID: 25648342
[TBL] [Abstract][Full Text] [Related]
3. Combined testosterone and vardenafil treatment for restoring erectile function in hypogonadal patients who failed to respond to testosterone therapy alone.
Yassin DJ; Yassin AA; Hammerer PG
J Sex Med; 2014 Feb; 11(2):543-52. PubMed ID: 24251448
[TBL] [Abstract][Full Text] [Related]
4. [Choice of treatment of erectile dysfunction associated with hypogonadism].
Aliaev IuG; Vinarov AZ; Akhvlediani ND
Urologiia; 2010; (4):37-8, 40-2. PubMed ID: 20967981
[TBL] [Abstract][Full Text] [Related]
5. Treatment of 161 men with symptomatic late onset hypogonadism with long-acting parenteral testosterone undecanoate: effects on body composition, lipids, and psychosexual complaints.
Permpongkosol S; Tantirangsee N; Ratana-olarn K
J Sex Med; 2010 Nov; 7(11):3765-74. PubMed ID: 20807330
[TBL] [Abstract][Full Text] [Related]
6. IPASS: a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 men.
Zitzmann M; Mattern A; Hanisch J; Gooren L; Jones H; Maggi M
J Sex Med; 2013 Feb; 10(2):579-88. PubMed ID: 22812645
[TBL] [Abstract][Full Text] [Related]
7. Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes.
Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P
J Sex Med; 2013 Jun; 10(6):1612-27. PubMed ID: 23551886
[TBL] [Abstract][Full Text] [Related]
8. Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life.
Yassin DJ; Doros G; Hammerer PG; Yassin AA
J Sex Med; 2014 Jun; 11(6):1567-76. PubMed ID: 24712761
[TBL] [Abstract][Full Text] [Related]
9. [Nebido in the treatment of hypogonadism syndrome and its complications in men].
Dedov II; Kurbatov DG; Rozhivanov RV; Lepetukhin AE; Dubskiĭ SA; Goncharov NP
Urologiia; 2011; (6):59-60, 62-7. PubMed ID: 22448484
[TBL] [Abstract][Full Text] [Related]
10. The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study).
Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P; Saghir A;
Int J Clin Pract; 2014 Feb; 68(2):203-15. PubMed ID: 24355040
[TBL] [Abstract][Full Text] [Related]
11. Testosterone undecanoate improves sexual function in men with type 2 diabetes and severe hypogonadism: results from a 30-week randomized placebo-controlled study.
Hackett G; Cole N; Saghir A; Jones P; Strange RC; Ramachandran S
BJU Int; 2016 Nov; 118(5):804-813. PubMed ID: 27124889
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of vardenafil for the treatment of erectile dysfunction in men with metabolic syndrome: results of a randomized, placebo-controlled trial.
Schneider T; Gleissner J; Merfort F; Hermanns M; Beneke M; Ulbrich E
J Sex Med; 2011 Oct; 8(10):2904-11. PubMed ID: 21771281
[TBL] [Abstract][Full Text] [Related]
13. [Effects of different treatments on endothelial function in patients with erectile dysfunction and hypogonadism].
Mazo EB; Gamidov SI; Sotnikova EM
Ter Arkh; 2008; 80(12):59-63. PubMed ID: 19227909
[TBL] [Abstract][Full Text] [Related]
14. Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism.
Giagulli VA; Carbone MD; Ramunni MI; Licchelli B; De Pergola G; Sabbà C; Guastamacchia E; Triggiani V
Andrology; 2015 Nov; 3(6):1094-103. PubMed ID: 26447645
[TBL] [Abstract][Full Text] [Related]
15. Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome.
Giltay EJ; Tishova YA; Mskhalaya GJ; Gooren LJ; Saad F; Kalinchenko SY
J Sex Med; 2010 Jul; 7(7):2572-82. PubMed ID: 20524974
[TBL] [Abstract][Full Text] [Related]
16. Oral testosterone replacement in Korean patients with PADAM.
Hong JH; Ahn TY
Aging Male; 2002 Mar; 5(1):52-6. PubMed ID: 12040976
[TBL] [Abstract][Full Text] [Related]
17. Sexual functions of men with obstructive sleep apnoea syndrome and hypogonadism may improve upon testosterone administration: a pilot study.
Zhuravlev VN; Frank MA; Gomzhin AI
Andrologia; 2009 Jun; 41(3):193-5. PubMed ID: 19400854
[TBL] [Abstract][Full Text] [Related]
18. Effects of 8-Year Treatment of Long-Acting Testosterone Undecanoate on Metabolic Parameters, Urinary Symptoms, Bone Mineral Density, and Sexual Function in Men With Late-Onset Hypogonadism.
Permpongkosol S; Khupulsup K; Leelaphiwat S; Pavavattananusorn S; Thongpradit S; Petchthong T
J Sex Med; 2016 Aug; 13(8):1199-211. PubMed ID: 27436076
[TBL] [Abstract][Full Text] [Related]
19. Injectable testosterone undecanoate for the treatment of hypogonadism.
Corona G; Maseroli E; Maggi M
Expert Opin Pharmacother; 2014 Sep; 15(13):1903-26. PubMed ID: 25080279
[TBL] [Abstract][Full Text] [Related]
20. Waist circumference is superior to weight and BMI in predicting sexual symptoms, voiding symptoms and psychosomatic symptoms in men with hypogonadism and erectile dysfunction.
Yassin AA; Nettleship JE; Salman M; Almehmadi Y
Andrologia; 2017 May; 49(4):. PubMed ID: 27400881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
